Sponsor Pipeline

Zheng Min Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
0
Recruiting
1
Disease Areas
Active Trials by Phase
Phase 2
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07348861 A Phase II Study of Neoadjuvant Sacituzumab Tirumotecan in Combination With Iparomlimab… Cervical Cancer Not Yet Recruiting
Disease Areas
Get alerts when Zheng Min's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free